SPP1 and cancer: Increasing evidence shows that SPP1 is overexpressed and involved in the progression and poor survival of many types of cancers, including hepatocellular carcinoma [14], glioblastoma [15], breast cancer [16], melanoma [17], colorectal cancer [18].